Atropine for myopia control.
The past five years has seen research and clinical practice focus on low-concentration atropine (0.01% to 0.05%) which appears to provide dose-related efficacy with minimal side effects, compared to higher concentrations.
The use of topical atropine for myopia control has decades of clinical and research history, but recent research has explored low concentrations, different formulations, and whether combination with optical treatments can boost myopia control results. New, preservative-free formulations are now superseding compounded preparations in scientific studies and adding to the story on the ideal concentration and target populations.
Follow the links on this page to learn more about atropine for slowing myopia progression.